Epicoccum nigrum Z01 and application thereof

By using culture medium or fermentation broth of Aconitum nigra Z01, the widespread problems of water mold disease in freshwater aquaculture industry have been solved, effective prevention and inhibition of water mold infection has been achieved, the risk of chemical drugs has been avoided, and the risk of using chemical drugs has been promoted. Sustainable development of freshwater fisheries.

CN119060857AActive Publication Date: 2024-12-03YANGTZE RIVER FISHERIES RES INST CHINESE ACAD OF FISHERY SCI
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411274519.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-12
Publication Date
2024-12-03
Estimated Expiration
2044-09-12

AI Technical Summary

Technical Problem

Aquamillitis is widely present in freshwater aquaculture. Traditional chemical drug control methods have residual problems, which poses a threat to the human body and the environment, and it is difficult to effectively prevent and inhibit water mold infection.

Method used

Epicococcus melanini Z01 (Epicococcusnigrum) is used as an antagonist fungus, and through its culture medium or fermentation broth as feed or drug form, it prevents and inhibits water mold infection and avoids the use of chemical drugs.

Benefits of technology

Effectively prevent and inhibit water mold infection, reduce the use of chemical drugs, reduce environmental and health risks, and promote the sustainable development of freshwater fisheries.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060857A_ABST
    Figure CN119060857A_ABST
Patent Text Reader

Abstract

The invention discloses epicoccum nigrum Z01 and application thereof in the technical field of microorganisms. The collection number of the Epicoccum nigrum Z01 is CCTCC (China Center For Type Culture Collection) NO: M2024967, and the collection number of the Epicoccum nigrum Z01 is CCTCC NO: M2024967. The epicoccum nigrum Z01 disclosed by the invention can be applied to a carrier for treating or preventing fungal infection so as to prevent and inhibit pathogenic bacteria, namely water mildew, from infecting aquatic animals in freshwater aquaculture.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to Echinococcus nigromaculata Z01 and application thereof, belonging to the technical field of microorganisms. Background Art

[0002] In freshwater aquaculture, Saprolegniasis (caused by Saprolegnia fungi, such as Saprolegnia) is a ubiquitous fungal disease that poses a major threat to aquatic animals, especially fish. The disease is not very selective for hosts and can infect all life stages of aquatic animals. Especially in low temperature seasons, its morbidity and mortality rates increase significantly, becoming one of the main causes of fish mortality. The infection mechanism of Saprolegnia is complex. Through its unique effector protein transport system, it can penetrate host cells, interfere with and inhibit the host's defense response, and ultimately lead to epidermal cell damage and tissue decay, seriously affecting the health and survival rate of farmed fish.

[0003] Grass carp (Ctenopharyngodon idella), as the first of the four major carps in my country, is not only valued for its extensive breeding base and high economic value, but also because it is a representative of scaled fish and is often selected as a model organism for studying the infection mechanism of Saprolegniasis. However, with the expansion of aquaculture scale and the complexity of aquaculture environment, the harm of Saprolegniasis to grass carp and other freshwater fish has become increasingly serious, seriously affecting the sustainable development of the aquaculture industry.

[0004] Traditionally, the control of Saprolegniasis relies on chemical drugs such as malachite green, but these drugs often have residue problems and pose a potential threat to human health, so their use is strictly restricted or even banned.

[0005] Therefore, the present invention provides Echinococcus nigromaculata Z01 and application thereof. Summary of the invention

[0006] The object of the present invention is to provide a kind of Echinococcus nigromaculata Z01 and application thereof, which can prevent and inhibit the pathogenic bacteria Saprolegnia nigromaculata from infecting aquatic animals in freshwater aquaculture.

[0007] The purpose of the present invention is achieved by the following technical solutions:

[0008] In one aspect, the present invention provides an Epicoccum nigrum Z01, and the preservation number of the Epicoccum nigrum Z01 is CCTCCNO: M2024967.

[0009] Furthermore, the Echinococcus nigromaculata Z01 exists in the form of living cells.

[0010] On the other hand, the present invention provides an application of Epicoccum nigrum Z01 in a vector for treating or preventing fungal infection. The deposit number of Epicoccum nigrum Z01 is CCTCCNO: M2024967.

[0011] Furthermore, the fungus is Saprolegnia.

[0012] Furthermore, the carrier is feed and / or medicine.

[0013] Furthermore, the drug is in the form of liquid, tablet, granule, pill or capsule.

[0014] Furthermore, the liquid preparation includes Epicoccum nigrum Z01 or its culture solution or fermentation solution.

[0015] Furthermore, the OD600 of the culture solution of the Echinococcus nigromatus Z01 is 1.2-1.5, and the OD430 of the fermentation solution of the Echinococcus nigromatus Z01 is 0.268.

[0016] Furthermore, the tablet, granule dosage form, pill or capsule comprises lyophilized powder of Echinococcus nigromaculata Z01.

[0017] Furthermore, the spore concentration of the lyophilized powder of E. nigrosinophila Z01 is 1.0-8.0×10 8 Pieces / g.

[0018] Compared with the prior art, the beneficial effects of the present invention include at least:

[0019] The Epicoccumnigrum Z01 of the present invention can prevent and inhibit the pathogenic bacteria Saprolegnia in freshwater aquaculture from infecting aquatic animals, avoids a series of environmental, animal protection and pathogenic bacteria resistance problems caused by the large-scale use of chemical pesticides, avoids the harm of drug residues to aquaculture objects and humans, and more importantly, promotes the green and ecological sustainable development of freshwater fisheries. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 2 is a photo of a dying grass carp according to an embodiment of the present invention.

[0021] Figure 2 This is a photograph of Echinococcus nigromaculata Z01 in a Saprolegnia culture medium according to an example of the present invention.

[0022] Figure 3 It is an agarose gel electrophoresis diagram of Saprolegnia polysperma CY01 and Echinococcus nigromaculata Z01 of the examples of the present invention.

[0023] Figure 4It is a phylogenetic tree of 16S rDNA sequences of Saprolegnia polysperma CY01, Echinococcus nigromaculata Z01 and related species in the embodiments of the present invention.

[0024] Figure 5 These are the experimental group and the blank control group of the first-generation flat plate confrontation experiment of the embodiment of the present invention.

[0025] Figure 6 This is a diagram showing the inhibitory effect of the fermentation liquid of Echinococcus nigromaculata Z01 on Saprolegnia sp. analyzed by the agar dilution method in an embodiment of the present invention.

[0026] Figure 7 This is a diagram showing the inhibitory effect of Echinococcus nigromaculata Z01 fermentation broth on Saprolegnia sp. analyzed by the liquid dilution method in an embodiment of the present invention.

[0027] Figure 8 This is a safety evaluation diagram of the effect of the culture solution of Echinococcus nigromaculata Z01 on the blood of grass carp according to an embodiment of the present invention.

[0028] Fig. 9 This is another safety evaluation diagram of the effect of the culture solution of Echinococcus nigromaculata Z01 on the blood of grass carp according to an embodiment of the present invention.

[0029] Fig.10 This is a safety evaluation diagram of the effect of the culture solution of Echinococcus nigromaculata Z01 on grass carp tissues according to an embodiment of the present invention.

[0030] Fig.11 This is a diagram showing the preventive effect of the culture solution of Echinococcus nigromaculata Z01 on grass carp infected with Saprolegnia polysperma CY01 according to an embodiment of the present invention.

[0031] Fig.12 This is another preventive effect diagram of the culture solution of Echinococcus nigromaculata Z01 in the embodiment of the present invention on grass carp infected with Saprolegnia polysperma CY01.

[0032] Fig.13 The invention discloses the effects of Saprolegnia CY01 and Echinococcus nigromaculata Z01 on grass carp tissues. DETAILED DESCRIPTION

[0033] Example embodiments will now be described more fully with reference to the accompanying drawings. However, example embodiments can be implemented in a variety of forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided to make the present invention more comprehensive and complete and to fully convey the concepts of example embodiments to those skilled in the art. The same reference numerals in the figures represent the same or similar structures, and thus their repeated description will be omitted.

[0034] The words expressing positions and directions described in the present invention are all explained with reference to the accompanying drawings as examples, but they can be changed as needed, and all such changes are included in the protection scope of the present invention.

[0035] Introduction to the strains, drugs and instruments involved in this application:

[0036] Potato dextrose agar medium was purchased from Qingdao Hi-Tech Industrial Park Haibo Biotechnology Co., Ltd.

[0037] Potato dextrose broth medium was purchased from Qingdao Hi-Tech Industrial Park Haibo Biotechnology Co., Ltd.

[0038] Giemsa staining solution was purchased from Beijing Solebow Technology Co., Ltd.

[0039] Sterile gauze is gauze that has been sterilized at high temperature. The gauze was purchased from Caoxian Hualu Sanitary Materials Co., Ltd. The production batch number is 23082501 and the specification model is 21s x 32s.

[0040] The Ezup column-based fungal genomic DNA extraction kit was purchased from Sangon Biotech (Shanghai) Engineering Co., Ltd.

[0041] Epicoccumnigrum Z01 was collected from the laboratory of the Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, and preserved in the China Type Culture Collection, address: Wuhan University, Wuhan, China, with the preservation number CCTCC NO: M2024967 and the preservation date May 16, 2024.

[0042] The present invention uses Giemsa staining to observe the morphology of blood cells, including:

[0043] Use soap or washing powder to boil the slide for 20 minutes, then rinse it repeatedly with hot water and tap water, and finally rinse it with distilled water for 3 to 5 times, or soak it in 95% alcohol for 1 hour and then wipe it dry or dry it for later use. Draw blood from the back of the grass carp and drop the blood on one end of the spare slide about 4mm to 5mm. Use a pusher to evenly spread the blood on the slide to form a thin and uniform blood film. After the blood film is dry, fix it with anhydrous methanol for 3 minutes, then use Giemsa staining solution, stain at room temperature for 15 minutes, and finally rinse it slowly from one end of the slide with distilled water, and examine it under a microscope after drying.

[0044] The method for calculating the number of leukocytes of the present invention includes (generally counting 5 times in parallel and taking the average value):

[0045] WBC count = A / N × M1 × 10 × 10 6

[0046] In the formula, N is the number of squares observed under a microscope, and N in the present invention is 4; M1 is the magnification of the blood smear, and M1 in the present invention is 20; A is the total number of white blood cells in the N squares observed under a microscope.

[0047] The paraffin section preparation of the present invention comprises:

[0048] The skin, liver, spleen, mesonephros, intestine and muscle tissues of grass carp were collected and immediately fixed in Bonn's solution. After fixation for 20 h, the tissues were transferred to alcohol solution for dehydration, and then embedded in paraffin, sectioned, stained with hematoxylin-eosin, and sealed with neutral gum. Then, they were observed and photographed under a microscope (Olympus BX51).

[0049] (I) Isolation and identification

[0050] 1.1 Isolation of Saprolegnia pathogens and antagonistic fungi strains:

[0051] From the breeding pond in Jingzhou, Hubei, a dying grass carp with wounds on its body surface was collected and recorded as grass carp A. Figure 1 Grass carp A had congestion around its eyes and at the base of its pelvic fins, and some scales had fallen off its body surface. Grass carp A was transported to the laboratory of the Yangtze Fisheries Research Institute, Chinese Academy of Fishery Sciences.

[0052] The body surface of grass carp A was sprayed with alcohol, the eyes of grass carp A were taken out, the lens was pierced with sterile tweezers, and the pierced lens was placed on potato dextrose agar medium and cultured at 25°C for 3 days, and hyphae grew on the potato dextrose agar medium.

[0053] Use a sterile scalpel to cut out a 5mmX5mm rectangular block covered with hyphae, and place the 5mmX5mm rectangular block covered with hyphae upside down on a new potato dextrose agar medium (with hyphae facing the potato dextrose agar medium), and culture it at 25°C for 3 days. Repeat this step until a single strain grows on the potato dextrose agar medium, and the white strain with hyphae is the Saprolegnia pathogen.

[0054] For the single yellowish strain on potato dextrose agar medium (there is an inhibition zone around the single yellowish strain), use a sterile scalpel to cut a 5mmX5mm yellowish rectangular block, and turn the 5mmX5mm yellowish rectangular block upside down on a new potato dextrose agar medium (the yellowish strain faces the potato dextrose agar medium), and culture it at 25℃ for 3 days. Until a single strain grows on the potato dextrose agar medium. Repeat this step until a single strain grows on the potato dextrose agar medium. 1.2 Purification of Saprolegnia pathogens and antagonistic fungi

[0055] After typical colonies appear on the potato dextrose agar medium, pick the white single colonies with the colony characteristics of standard Saprolegnia, the colony characteristics of standard Epicoccumnigrum, and the yellow single colonies that produce inhibition zones (inhibit Saprolegnia pathogens) for reference. Figure 2 .

[0056] The two groups of selected single colonies were cultured three times in a row respectively. The colony morphology in the culture medium was consistent and the cell morphology of the strain was single, that is, the pure strain of the Saprolegnia pathogen and the pure strain of the antagonistic fungus were obtained.

[0057] 1.3 Biological identification of pathogenic bacteria and antagonistic fungal strains:

[0058] The specific method refers to the instructions of the fungal DNA extraction kit (Ezup column fungal genomic DNA extraction kit) to extract the DNA of the Saprolegnia pathogen and the antagonistic fungal strain respectively.

[0059] ITS rDNA analysis

[0060] The universal primers ITS1 and ITS4 of the fungal ITS region were used to identify pathogens and antagonistic fungal strains: Primer ITS1: 5'-TCCGTAGGTGAACCTGCGG-3'; Primer ITS4 (5'-TCCTCCGCTTATTGATATGC-3').

[0061] PCR reaction system: using the extracted genome as template, the total system is 50 μl: 25 μl ExTaq enzyme, 2 μl primer ITS1, 2 μl primer ITS4, 2 μl template, add double distilled water to make up to 50 μl.

[0062] PCR amplification conditions: pre-denaturation at 95°C for 3 min. Enter 35 cycles: denaturation at 95°C for 30 s, annealing at 55°C for 30 s, extension at 72°C for 1 min. Final extension at 72°C for 10 min. Terminate the reaction at 4°C.

[0063] After amplification, 5 μl of the PCR product was subjected to 1% agarose gel electrophoresis, and the amplified product was sent to Wuhan Tianyi Huiyuan Biotechnology Co., Ltd. for sequencing. The sequencing results were aligned using GenBank blast, and the phylogenetic tree was constructed using the neighbor-joining method using MEGA5.0 software.

[0064] Figure 3 M is the standard template, 1, 2, 3 and 4 are pathogenic bacteria, and 5 and 6 are antagonistic fungal strains. Figure 3 It can be seen that the length of the 16SrDNA sequence of the pathogen is 708bp, and the length of the 16SrDNA sequence of the antagonistic fungus strain is 527bp. Figure 4 The pathogen was grouped together with Saprolegnia ferax (Accession No.: AY270032.1). Based on morphological and molecular biological characteristics, the pathogen was identified as Saprolegnia ferax and named Saprolegnia ferax CY01. Figure 4The antagonistic fungus strain has a homology of up to 100% with Epicoccumnigrum, and is clustered together with Epicoccumnigrum (accession number: OQ555113.1). Based on morphological and molecular biological characteristics, the antagonistic fungus strain was identified as Epicoccumnigrum and named Epicoccumnigrum Z01.

[0065] The nucleotide sequence of Escherichia cocci Z01 is as follows:

[0066] GGGTGACCTGCGGAAGGATCATTACCTAGAGTTTGTAGACTTCGGTCTGCTACCTCTT

[0067] ACCCATGTCTTTTGAGTACCTTCGTTTCCCTCGGCGGGTCCGCCCGCCGATTGGACAAC

[0068] ATTCAAACCCTTTGCAGTTGCAATCAGCGTCTGAAAAAACATAATAGTTACAACTTTC

[0069] AACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTA

[0070] GTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCCTTG

[0071] GTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACCTTCAAGCTCTGCTTGGTGT

[0072] TGGGGTTTTGTCTCGCCTCTGCGTGTAGACTCGCCTTAAAACAATTGGCAGCCGGCG

[0073] TATTGATTTCGGAGCGCAGTACATCTCGCGCTTTGCACTCATAACGGCGACGTCCAAA

[0074] AGTACATTTTTACACTCTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCAT

[0075] ATCT

[0076] The nucleotide sequence of Saprolegnia multifida CY01 is as follows:

[0077] GAAGGATCATTACCACACCAAAAAACACCCCACGTGAATGTACTCTTTATGAGGCTTG

[0078] CGCTGCCCTTGTGGCGGCTAGCCGAAGGTTTCGCAAGAAGCCGATGTCAATTTGAATC

[0079] CTTTTTAAACTACGACTGATCAAAACTGCAGATAGAAATGTCTGCATGCAATTGAAATA

[0080] CAACTTTCAACAGTGGATGTCTAGGCTCGCACACCGATGAAGAACGCTGCGAACTGC

[0081] GATACGTAATGCGAATTGCAGAATTCAGTGAGTCATCAAAATTTTGAACGCATATTGCA

[0082] CTTCCGGGTTAGTCCTGGGAGTATGTTTGTATCAGTGTCCGTGAACACAACCTTGTTTC

[0083] ATTTCTTGATTGAGATGGAGCAGAATGTGAAGGTCTTGTAATTACAAGTCCTTTTAAAC

[0084] GACGGTACCTATGCGTCCTCGTGAGATGTATTATTTAAAGGTATGCCTGCGCTTCTTTC

[0085] GAGAGTTTTGTGTGGCGGCACACAGCATTCAAAGAGAGAGCAAATCGCGGTAGTTTT

[0086] GCTTGTATTTCGGTACGAGTGGACACATATTGCTTTTTGTGATTTCTGCGAGTCTGTTG

[0087] TTTAAGCACAGGACACGTAAGGAGAGTGAGTATGCTGGTGCATTTCTTGGCGCATGGA

[0088] GGCAAATTGGGAATTCAATCCAATTTGGACCTGATATCAAACAAGACTACCCGCTGAA

[0089] CTTAAGCA

[0090] (II) Antagonistic activity against antagonistic fungi and stability of subculture

[0091] The primary Saprolegnia polysperma CY01 purified in 1.2 was used as the test strain, and the primary Ephemerococcus nigromaculata Z01 purified in 1.2 was used as the antagonistic fungal strain, and the agar transfer method was used for plate confrontation experiment.

[0092] 2.01 Generation Tablet Confrontation Experiment

[0093] Experimental group: A 6mm diameter Saprolegnia CY01 agar block was placed upside down in the center of the potato dextrose agar medium, with the side with Saprolegnia mycelium close to the surface of the potato dextrose agar medium. At the same time, a 5mmx5mm Nigrococcus Z01 agar block was placed upside down 25mm on both sides of the Saprolegnia CY01 agar block.

[0094] Blank control group: a piece of Saprolegnia multifida CY01 agar block with a diameter of about 6 mm was placed upside down in the center of the potato dextrose agar medium, with the side with Saprolegnia mycelium close to the surface of the potato dextrose agar medium.

[0095] The potato dextrose agar medium of the experimental group and the blank control group was placed in a 25°C constant temperature incubator and inverted for 3 days to observe the confrontation results. Figure 5 , where a is the blank control group and b is the experimental group.

[0096] 2.02 Second generation tablet confrontation experiment

[0097] Experimental group: The difference from the experimental group of the first-generation plate confrontation experiment is that the E. nigrosinus Z01 agar block was removed from the experimental group of the first-generation plate confrontation experiment using a sterile scalpel.

[0098] Blank control group: the same as the experimental group in the first-generation plate confrontation experiment.

[0099] Other culture conditions were the same as those in the first-generation plate confrontation experiment.

[0100] 2.03 Three-generation tablet confrontation experiment

[0101] Experimental group: The difference from the experimental group of the first-generation plate confrontation experiment is that the agar block of Escherichia coli Z01 was taken from the experimental group of the second-generation plate confrontation experiment using a sterile scalpel.

[0102] Blank control group: the same as the experimental group in the first-generation plate confrontation experiment.

[0103] Other culture conditions were the same as those in the first-generation plate confrontation experiment.

[0104] 2.04 Four-generation tablet confrontation experiment

[0105] Experimental group: The difference from the experimental group of the first generation plate confrontation experiment is that the agar block of Escherichia coli Z01 was taken from the experimental group of the third generation plate confrontation experiment using a sterile scalpel.

[0106] Blank control group: the same as the experimental group in the first-generation plate confrontation experiment.

[0107] Other culture conditions were the same as those in the first-generation plate confrontation experiment.

[0108] 2.05 Five-generation tablet confrontation experiment

[0109] Experimental group: The difference from the experimental group of the first generation plate confrontation experiment is that the agar block of Escherichia coli Z01 was taken from the experimental group of the fourth generation plate confrontation experiment using a sterile scalpel.

[0110] Blank control group: the same as the experimental group in the first-generation plate confrontation experiment.

[0111] Other culture conditions were the same as those in the first-generation plate confrontation experiment.

[0112] 2.06 Six-generation tablet confrontation experiment

[0113] Experimental group: The difference from the experimental group of the first generation plate confrontation experiment is that the agar block of Escherichia coli Z01 was taken from the experimental group of the fifth generation plate confrontation experiment using a sterile scalpel.

[0114] Blank control group: the same as the experimental group in the first-generation plate confrontation experiment.

[0115] Other culture conditions were the same as those in the first-generation plate confrontation experiment.

[0116] 2.07 Seventh generation tablet confrontation experiment

[0117] Experimental group: The difference from the experimental group of the first generation plate confrontation experiment is that the agar block of Escherichia coli Z01 was taken from the experimental group of the sixth generation plate confrontation experiment using a sterile scalpel.

[0118] Blank control group: the same as the experimental group in the first-generation plate confrontation experiment.

[0119] Other culture conditions were the same as those in the first-generation plate confrontation experiment.

[0120] 2.08 Eighth generation flat panel confrontation experiment

[0121] Experimental group: The difference from the experimental group of the first generation plate confrontation experiment is that the agar block of Escherichia coli Z01 was taken from the experimental group of the seventh generation plate confrontation experiment using a sterile scalpel.

[0122] Blank control group: the same as the experimental group in the first-generation plate confrontation experiment.

[0123] Other culture conditions were the same as those in the first-generation plate confrontation experiment.

[0124] 2.09 Nine-generation tablet confrontation experiment

[0125] Experimental group: The difference from the experimental group of the first generation plate confrontation experiment is that the agar block of Escherichia coli Z01 was taken from the experimental group of the eighth generation plate confrontation experiment using a sterile scalpel.

[0126] Blank control group: the same as the experimental group in the first-generation plate confrontation experiment.

[0127] Other culture conditions were the same as those in the first-generation plate confrontation experiment.

[0128] 2.10 Tenth generation tablet confrontation experiment

[0129] Experimental group: The difference from the experimental group of the first generation plate confrontation experiment is that the agar block of Escherichia coli Z01 was taken from the experimental group of the ninth generation plate confrontation experiment using a sterile scalpel.

[0130] Blank control group: the same as the experimental group in the first-generation plate confrontation experiment.

[0131] Other culture conditions were the same as those in the first-generation plate confrontation experiment.

[0132] Each group of experiments was set up in triplicate. The antagonistic activity of E. nigrosinus Z01 was observed in each generation of plate confrontation experiments, and its stability was determined by measuring the size of the inhibition zone of E. nigrosinus Z01, as shown in Table 1.

[0133] Table 1 Inhibitory effect of Echinococcus nigromaculata Z01 on Saprolegnia

[0134]

[0135] Note: The data in Table 1 are mean ± standard deviation.

[0136] After ten passages, the diameter of the inhibition zone of Nigrococcus Z01 narrowed slightly, which means that the antagonistic activity was slightly weakened. It may be that the culture conditions did not reach the optimal growth state of Nigrococcus Z01, which induced the appearance of degenerate spores, promoted the rapid reproduction and degeneration of degenerate spores, and when the number was much larger than that of normal cells, the antibacterial activity of Nigrococcus Z01 was weakened. There was no significant difference in the antibacterial effect between the subculture strain of Nigrococcus Z01 and the original strain of Nigrococcus Z01 (P>0.05). In short, the antagonistic activity of Nigrococcus Z01 is generally stable and will not disappear with the increase of passage times.

[0137] (III) Inhibitory effects of culture fluid and fermentation fluid of antagonistic fungi on Saprolegnia

[0138] 3.1 Preparation of culture medium and fermentation broth of Escherichia cocci Z01

[0139] 3.1.1 Preparation of culture medium of Escherichia cocci Z01

[0140] The primary E. nigrosinus Z01 purified in 1.2 was inoculated into 200 mL of potato dextrose broth medium and cultured in a shaker at 175 rpm and 25° C. for 5 days. Then, the strain culture solution was filtered through three layers of sterile gauze to obtain the filtrate as the E. nigrosinus Z01 culture solution. The OD600 of the E. nigrosinus Z01 culture solution was 1.2-1.5.

[0141] 3.1.2 Preparation of Fermentation Broth of Escherichia cocci Z01

[0142] The filtrate was centrifuged at a speed of 10,000 r / min for 10 minutes to remove solid impurities in the culture solution of the black-attached coccus Z01 to obtain a supernatant. Then, the supernatant was filtered with a 0.22 μm filter membrane to obtain a black-attached coccus Z01 fermentation solution. The OD430 of the fermentation solution of the black-attached coccus Z01 was 0.268.

[0143] 3.2 Inhibitory effect of the fermentation broth of E. nigrosinum Z01 on Saprolegnia

[0144] 3.2.1 Agar dilution method

[0145] Experimental group: Before placing on the plate, the fermentation liquid of E. nigrosinus Z01 with OD430 = 0.268 was mixed evenly with potato dextrose agar medium in a certain ratio (1:9, 2:8, 3:7, 4:6, 5:5), and then poured onto the plate to obtain mixed plates with a ratio of 1:9, 2:8, 3:7, 4:6, 5:5. Then, the primary Saprolegnia CY01 purified in 1.2 was inoculated on each mixed plate and placed at a constant temperature of 25°C for 3 days to observe the mycelial growth of Saprolegnia CY01 on each mixed plate.

[0146] Blank control group: The primary Saprolegnia CY01 purified in 1.2 was inoculated on 100% potato dextrose agar medium and cultured at 25°C for 3 days to observe the mycelial growth of Saprolegnia CY01 on 100% potato dextrose agar medium.

[0147] Three parallel experiments were set up for each experimental group and blank control group.

[0148] refer to Figure 6 , the mixed plates added with the fermentation broth of E. nigrosinus Z01 significantly inhibited the growth of Saprolegnia multisperma CY01. When the ratio of the fermentation broth of E. nigrosinus Z01 to the potato dextrose agar medium was greater than 3:7, the growth of Saprolegnia multisperma CY01 was completely inhibited.

[0149] 3.2.2 Liquid dilution method

[0150] In a 24-well plate, a 5mmx5mm agar block covered with Saprolegnia CY01 was placed in the well, and 2mL, 1mL, 0.5mL, 0.25mL, 0.1mL, and 0mL (blank group) of Nigrococcus Z01 fermentation liquid were added, and potato dextrose broth medium was used to make up to 2mL. Three parallels were set for each treatment, and the culture was placed at a constant temperature of 25℃ for 48h. The mycelial growth of Saprolegnia CY01 was tracked under an optical microscope.

[0151] refer to Figure 7 In the blank group, due to the absence of the fermentation liquid of Nigrococcus Z01, the mycelium of Saprolegnia CY01 was thick, and the spores of Saprolegnia CY01 were active and continued to germinate. In the experimental group, although 0.1 mL of the fermentation liquid of Nigrococcus Z01 was added, due to the low concentration of the fermentation liquid of Nigrococcus Z01, very few germinating spores of Saprolegnia CY01 could still be found under an optical microscope. In other experimental groups, due to the high concentration of the fermentation liquid of Nigrococcus Z01, no germinated spores of Saprolegnia CY01 were observed. In addition, compared with the blank group, the mycelium of Saprolegnia CY01 in the experimental group was thinner. (IV) Application of culture liquid of antagonistic fungi on fish

[0152] 4.1 Safety evaluation of the culture medium of E. nigrosinophilus Z01 on grass carp

[0153] After 14 days of temporary culture, grass carp weighing 70-100 g were divided into a blank control group and a safety evaluation group. Three parallel groups were set up for each experiment, and 20 grass carps were set in each parallel group.

[0154] Safety evaluation group: Add the culture solution of Escherichia cocci Z01 into the aquaculture water, and the final concentration of Escherichia cocci Z01 spores is 2.0×10 8 Spores / mL, cultured at 25℃ for 7 days.

[0155] Blank control group: Add sterile potato dextrose broth medium into the aquaculture water and culture at 25℃ for 7 days.

[0156] The volume of sterile potato dextrose broth medium added to the blank control group was the same as the volume of E. nigrosinophilus Z01 culture medium added to the safety evaluation group.

[0157] Blood was collected from grass carp for white blood cell count and hemoglobin value detection; the collected blood was stained with Giemsa to observe the morphology of blood cells. At the same time, liver, spleen, mesonephros and intestine were taken for paraffin sections.

[0158] During the 7-day observation period, no grass carp died in either the blank group or the safety evaluation group. Figure 8 As shown, the number of white blood cells in the safety evaluation group increased significantly compared with the blank group (P<0.05), and the hemoglobin value of the fish body increased significantly after immersion in culture medium Z01. Fig. 9 , ...

[0159] Fig.10 Pathological sections of the liver, spleen, mesonephros and intestine of grass carp soaked in the culture medium of E. mesonephros Z01 were taken. Fig.10 It can be seen that: in the liver tissue, the hepatic plates are scattered around the central vein, the hepatocytes are irregular polygons, the cytoplasm content is small, and they are vacuolated. The spleen is mainly composed of dense red blood cells, and a large number of brown granules can be seen. The renal tubular structure of the mesonephric tissue is clear, a small amount of brown granules can be seen, and no obvious inflammatory cell infiltration is observed. The intestinal villus epithelium proliferates, the cells are arranged irregularly, and epithelial punctate necrosis is occasionally seen without obvious inflammatory cell infiltration. It can be seen that after being immersed in the culture solution of E. mesococcus Z01 for 7 days, the grass carp is safe and undamaged.

[0160] 4.2 Application of the culture medium of E. nigrococcus Z01 to prevent grass carp from being infected with Saprolegnia polysperma CY01

[0161] 60 grass carps (70-100g) of uniform physique were randomly divided into 4 aquariums and divided into positive control group, immersion group, gavage group and injection group. Before the experiment, wounds of equal size were made in the same part of each grass carp in the positive control group, immersion group, gavage group and injection group, and infected with Saprolegnia multifida CY01 (for details, please refer to the method of infection with Saprolegnia in the paper "Construction and Application of Fish Saprolegnia Disease Model" published by Xu Jialu in the Journal of Shanghai Ocean University in 2012).

[0162] Soaking group: Add the culture solution of Echinococcus nigromaculata Z01 into the aquaculture water, and the final concentration of Echinococcus nigromaculata Z01 spores is 1.0×10 8 Z01 spores / mL, and the water temperature was maintained at 18°C.

[0163] Injection group: The concentration of E. nigrosinophilus Z01 spores was 1.0×10 8 200 μl of E. nigrosinophilus Z01 culture solution with spores / mL was injected into the muscles of grass carp, and the water temperature was maintained at 18°C.

[0164] Intragastric administration group: The concentration of E. nigrosinophilus Z01 spores was 1.0×10 8 200 μl of the culture medium of E. nigrosinophilus Z01 with a spore / mL was injected into the abdomen of grass carp, and the water temperature was maintained at 18°C.

[0165] Positive control group: Add potato dextrose broth culture medium into the aquaculture water and maintain the water temperature at 18℃.

[0166] The volume of potato glucose broth medium added to the positive control group was the same as the volume of E. nigrosinus Z01 culture medium added to the immersion group. The infection rate of Saprolegnia was calculated based on the presence of hyphae on the surface of grass carp. At the same time, blood was collected from grass carp and the morphology of blood cells was observed using Giemsa staining.

[0167] refer to Fig.11 The difference in the cumulative infection rate of the injection group, immersion group and gavage group with the positive control group at 7 days was significant (P<0.05). Specifically, the cumulative infection rate of the positive control group at 7 days was 80%, the cumulative infection rate of the injection group at 7 days was 30%, the cumulative infection rate of the immersion group at 7 days was 20%, and the cumulative infection rate of the gavage group at 7 days was 40%. It can be seen that when grass carp is threatened by Saprolegnia multifida CY01 infection, E. nigrococcus Z01 can significantly reduce the infection rate of grass carp.

[0168] Fig.12 a is the positive control group; b is the immersion group; c is the injection group; d is the gavage group. Fig.12 Compared with the positive control group, the blood cell morphology of grass carp in the injection group, immersion group and gavage group did not change, but the white blood cell content of each group increased slightly, and the difference between the immersion group and other groups was significant. After infection with Saprolegnia, the hemoglobin value of each group decreased significantly, but the immersion group, injection group and gavage group did not form a significant difference with the positive control group. It can be seen that E. nigrococcus Z01 has no safety impact on the tested grass carp.

[0169] 4.3 Application of the culture medium of E. nigrosinum Z01 on grass carp infected with Saprolegnia polysperma CY01

[0170] Thirty grass carps successfully infected with Saprolegnia polysperma CY01 (hyphae visible at the wound sites of the fish bodies) were evenly divided into a treatment group and an infection group, with three parallel groups in each group.

[0171] Treatment group: Add the culture solution of Echinococcus nigromaculata Z01 into the aquaculture water, and the final concentration of Echinococcus nigromaculata Z01 spores is 2.0×10 8 spores / mL, soak for 3 consecutive days, each soaking time is 1 hour, and the soaking temperature is 25℃.

[0172] Infection group: Add potato dextrose broth medium into the aquaculture water and soak for 3 consecutive days, each soaking time is 1 hour, and the soaking temperature is 25℃.

[0173] The volume of potato dextrose broth added to the infection group was the same as the volume of E. nigrosinus Z01 culture fluid added to the treatment group. Blood was collected for leukocyte count and hemoglobin value testing for 7 consecutive days, and the intestine, skin, muscle, and liver were collected for paraffin sections.

[0174] Compared with healthy grass carp, the white blood cell count of the infected grass carp fluctuated slightly, but the hemoglobin content was significantly reduced.

[0175] refer to Fig.13 Compared with healthy grass carp, the skin, muscle, intestine and liver of the grass carp in the infection group showed different degrees of lesions. The epidermis of grass carp treated with Saprolegnia was slightly thinned; the pigment layer showed a large reduction in pigment; a large number of muscle cells were necrotic, cytoplasmic fragmentation, and irregular cell arrangement in muscle tissue; irregular villi were occasionally seen in intestinal tissue; the mucosal epithelium was intact, the lamina propria had a large number of cells reduced, and the mucosal epithelium was separated from the lamina propria; the liver tissue showed diffuse watery hepatocyte degeneration, and the cytoplasm was loose and lightly stained, which was the earliest change in cell damage.

[0176] Compared with healthy grass carp, no obvious difference was found in the epidermis of grass carp in the treatment group; a slight reduction in pigmentation and uneven distribution was observed in the pigment layer; a decrease in the number of cells in the lamina propria of the intestinal villi was occasionally seen in the intestinal tissue; diffuse ballooning degeneration of hepatocytes, edema of cells, cytoplasmic vacuolation, and swelling like balloons in severe cases were seen in the liver tissue.

[0177] In the infection group, the skin surface of grass carp infected with Saprolegnia decreased a lot of pigment in the pigment layer, while in the treatment group, the pigment layer of grass carp increased significantly after being treated with the culture medium of E. nigromaculata Z01; the muscle tissue in the infection group was severely damaged when infected with Saprolegnia, and the muscle cells were severely necrotic; in the treatment group, the number of cells in the lamina propria of grass carp tended to increase after being treated with the culture medium of E. nigromaculata Z01. However, compared with healthy grass carp, there was no significant change in the liver tissue of grass carp in the infection group and the treatment group.

[0178] It can be seen that the black coccus Z01 of the present invention and its culture liquid and fermentation liquid can be used in the carrier for treating or preventing fungal infection (such as Saprolegnia). Among them, the carrier includes feed and medicine. The form of the medicine includes liquid, tablet, granule, pill or capsule. When used, the tablet, granule, pill or capsule includes black coccus Z01 freeze-dried powder. The bacterial concentration of black coccus Z01 freeze-dried powder is 1.0-8.0×10 8 Pieces / g.

[0179] Although the embodiments of the present invention have been shown and described above, it is to be understood that the above embodiments are exemplary and are not to be construed as limitations on the present invention. A person skilled in the art may change, modify, substitute and modify the above embodiments within the scope of the invention without departing from the principles and purpose of the present invention. All such changes should fall within the scope of protection of the claims of the present invention.

Claims

1. A black coccus Z01, It is characterized in that The deposit number of the Epicoccumnigrum Z01 is CCTCCNO: M2024967.

2. The Echinococcus nigromaculata Z01 according to claim 1, It is characterized in that The Echinococcus nigromaculata Z01 exists in the form of living cells.

3. Use of Epicoccum nigrum Z01 in a vector for treating or preventing fungal infection, wherein the deposit number of Epicoccum nigrum Z01 is CCTCCNO: M2024967.

4. The use according to claim 3, It is characterized in that The fungus is Saprolegnia.

5. The use according to claim 3, It is characterized in that The carrier is feed and / or medicine.

6. The use according to claim 5, It is characterized in that The drug may be in the form of liquid, tablet, granule, pill or capsule.

7. The use according to claim 6, It is characterized in that The liquid preparation includes Epicoccum nigrum Z01 or its culture solution or fermentation solution.

8. The use according to claim 7, It is characterized in that The OD600 of the culture solution of the Echinococcus nigromatus Z01 is 1.2-1.5, and the OD430 of the fermentation solution of the Echinococcus nigromatus Z01 is 0.

268.

9. The use according to claim 6, It is characterized in that The tablet, granule dosage form, pill or capsule comprises lyophilized powder of Echinococcus nigromaculata Z01.

10. The use according to claim 9, It is characterized in that The spore concentration of the lyophilized powder of Escherichia coccus Z01 is 1.0-8.0×10 8 Pieces / g.

Citation Information

Patent Citations

  • Epicoccum nigrum and application thereof

    CN106119136A

  • Epicoccum nigrum FXZ2 and application thereof

    CN106591156A

  • Biological control fungus epicoccum nigrum H5 and application thereof

    CN107779403A

  • Epicoccum nigrum fermentation product as well as preparation method and application thereof

    CN114703069A

  • Coenzyme-binding glucose dehydrogenase

    CN1726277A